Nova Southeastern University-ko ikertzaileekin lankidetzan egindako argitalpenak (20)

2023

  1. The Lysyl Oxidase G473A Polymorphism Exacerbates Oral Cancer Development in Humans and Mice

    International Journal of Molecular Sciences, Vol. 24, Núm. 11

2021

  1. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 168-190

2019

  1. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

    Journal of Allergy and Clinical Immunology, Vol. 143, Núm. 3, pp. 864-879

  2. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

    Clinical and Translational Allergy, Vol. 9, Núm. 1

  3. Next-generation ARIA care pathways for rhinitis and asthma: A model for multimorbid chronic diseases

    Clinical and Translational Allergy, Vol. 9, Núm. 1

2018

  1. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

    Clinical and Translational Allergy, Vol. 8, Núm. 1

2017

  1. Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)(Clin Transl Allergy (2016) 6 (29) DOI: 10.1186/s13601-016-0116-9)

    Clinical and Translational Allergy

  2. Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015

    The Lancet, Vol. 390, Núm. 10091, pp. 231-266

2016

  1. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

    Clinical and Translational Allergy, Vol. 6, Núm. 1

  2. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

    Journal of Allergy and Clinical Immunology, Vol. 138, Núm. 2, pp. 367-374.e2

  3. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

    Clinical and Translational Allergy, Vol. 6, Núm. 1

2015

  1. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

    The Lancet, Vol. 385, Núm. 9963, pp. 117-171

  2. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

    The Lancet, Vol. 386, Núm. 10010, pp. 2287-2323

  3. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: Quantifying the epidemiological transition

    The Lancet, Vol. 386, Núm. 10009, pp. 2145-2191

  4. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

    The Lancet, Vol. 386, Núm. 9995, pp. 743-800

  5. MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 70, Núm. 11, pp. 1372-1392

2014

  1. Integrated care pathways for airway diseases (AIRWAYS-ICPs)

    European Respiratory Journal, Vol. 44, Núm. 2, pp. 304-323

2012

  1. Common values in assessing health outcomes from disease and injury: Disability weights measurement study for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2129-2143

  2. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223

  3. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010

    The Lancet, Vol. 380, Núm. 9859, pp. 2163-2196